Linked from

The 22 pages that link to Venous thromboembolism, each with the reason it gives.

• Cushing syndromeRelated: Cushing syndrome increases clotting risk, particularly around surgery and active disease.

• Hormone replacement therapyRelated: Clot risk is one consideration in choosing hormone formulation, route, and eligibility.

• Combined oral contraceptive pillRelated: Estrogen-containing pills raise clot risk, making personal risk factors relevant to prescribing.

• Nephrotic syndromeRelated: Urinary loss of anticoagulant proteins and increased clotting factors raise thrombotic risk.

• Maternal healthRelated: Pregnancy and the postpartum period increase clotting risk, making prevention and recognition relevant.

• Gender-affirming hormone therapyRelated: Estrogen treatment can affect clot risk, which varies with formulation and individual health factors.

• Hormonal contraceptionRelated: Estrogen-containing methods raise clot risk for some users.

• CatatoniaRelated: Immobility during stuporous catatonia increases clot risk and can require preventive care.

• Testosterone replacement therapyRelated: Thrombotic risk is considered during prescribing, especially when other risk factors are present.

• TamoxifenRelated: Tamoxifen raises the risk of these potentially serious clots.

• Hip fractureRelated: Fracture, surgery, and immobility raise clot risk, prompting prevention and monitoring.

• EthinylestradiolRelated: Ethinylestradiol-containing contraceptives increase clot risk compared with nonuse.

• Klippel–Trénaunay syndromeRelated: Abnormal deep veins can increase the risk of serious clotting complications.

• Acute medicineRelated: Acute assessment must recognise potentially fatal pulmonary embolism among patients with breathlessness or chest pain.